Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 37Completed 19Active not recruiting 18Not yet recruiting 10Terminated 3Enrolling by invitation 3Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Neoplasm Metastasis 5Colorectal Neoplasms 5Breast Neoplasms 5Neoplasms 4Multiple Myeloma 4Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Leukemia, Myeloid, Acute 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Solid Tumor 2Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Osteosarcoma 2Mesothelioma, Malignant 2Melanoma 2Lymphoma, T-Cell 2Lung Neoplasms 2Immunoblastic Lymphadenopathy 2Glioblastoma 2Carcinoma, Renal Cell 2Carcinoma 2Biliary Tract Neoplasms 2Urinary Bladder Neoplasms 1Spinal Diseases 1Spinal Cord Neoplasms 1Solid Tumors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Head and Neck Neoplasms × 30 days × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡